Request for Free Sample

Table of Content

1. Introduction

1.1 Market Definition

1.2 Scope (Inclusion and Exclusions)

1.3 Research Assumptions

2. Executive Summary

2.1 Market Overview

2.2 Regional Synopsis

2.3 Competitive Summary

3. Research Methodology

3.1 Top-Down Approach

3.2 Bottom-up Approach

3.3. Data Validation

3.4 Primary Interviews

4. Market Dynamics Impact Analysis

4.1 Market Driving Factors Analysis

4.1.2 Drivers

4.1.2 Restraints

4.1.3 Opportunities

4.1.4 Challenges

4.2 PESTLE Analysis

4.3 Porter’s Five Forces Model

5. Statistical Insights and Trends Reporting

5.1 Vaccination Coverage & Prescription Trends (2024), by Region

5.2 Vaccine Volume Trends (Production & Distribution)

5.3 Healthcare Spending on Shingles Vaccination (Government, Insurance, Out-of-Pocket)

5.4 Patient Demographics and Uptake Behaviour (2024)

6. Competitive Landscape

6.1 List of Major Companies By Region

6.2 Market Share Analysis By Region

6.3 Product Benchmarking

6.3.1 Product specifications and features

6.3.2 Pricing

6.4 Strategic Initiatives

6.4.1 Marketing and promotional activities

6.4.2 Distribution and Supply Chain Strategies

6.4.3 Expansion Plans and New Product Launches

6.4.4 Strategic partnerships and collaborations

6.5 Technological Advancements

6.6 Market Positioning and Branding

7. Shingles Vaccine Market Segmentation By Product

7.1 Chapter Overview

7.2 Shingrix

        7.2.1 Shingrix Trend Analysis (2021-2032)

7.2.2 Shingrix Market Size Estimates and Forecasts to 2032 (USD Billion)

7.3 SKYZoster

       7.3.1 SKYZoster Market Trends Analysis (2021-2032)

       7.3.2 SKYZoster Market Size Estimates and Forecasts to 2032 (USD Billion)

7.4 Zostavax

       7.4.1 Zostavax Market Trends Analysis (2021-2032)

       7.4.2 Zostavax Market Size Estimates and Forecasts to 2032 (USD Billion)

8. Shingles Vaccine Market Segmentation By Vaccine Type

8.1 Chapter Overview

8.2 Live Attenuated Vaccine

        8.2.1 Live Attenuated Vaccine Market Trends Analysis (2021-2032)

8.2.2 Live Attenuated Vaccine Market Size Estimates and Forecasts to 2032 (USD Billion)

8.3 Recombinant Vaccine

      8.3.1 Recombinant Vaccine Market Trends Analysis (2021-2032)

      8.3.2 Recombinant Vaccine Market Size Estimates and Forecasts to 2032 (USD Billion)

9. Regional Analysis

     9.1 Chapter Overview

     9.2 North America

9.2.1 Trends Analysis

9.2.2 North America Shingles Vaccine Market Estimates and Forecasts, by Country (2021-2032) (USD Billion)

9.2.3 North America Shingles Vaccine Market Estimates and Forecasts, By Product (2021-2032) (USD Billion) 

9.2.4 North America Shingles Vaccine Market Estimates and Forecasts, By Vaccine Type (2021-2032) (USD Billion)

9.2.5 USA

9.2.5.1 USA Shingles Vaccine Market Estimates and Forecasts, By Product (2021-2032) (USD Billion)

9.2.5.2 USA Shingles Vaccine Market Estimates and Forecasts, By Vaccine Type (2021-2032) (USD Billion)

9.2.6 Canada

9.2.6.1 Canada Shingles Vaccine Market Estimates and Forecasts, By Product (2021-2032) (USD Billion)

9.2.6.2 Canada Shingles Vaccine Market Estimates and Forecasts, By Vaccine Type (2021-2032) (USD Billion)

9.2.7 Mexico

9.2.7.1 Mexico Shingles Vaccine Market Estimates and Forecasts, By Product (2021-2032) (USD Billion)

9.2.7.2 Mexico Shingles Vaccine Market Estimates and Forecasts, By Vaccine Type (2021-2032) (USD Billion)

9.3 Europe

9.3.1 Trends Analysis

9.3.2 Europe Shingles Vaccine Market Estimates and Forecasts, by Country (2021-2032) (USD Billion)

9.3.3 Europe Shingles Vaccine Market Estimates and Forecasts, By Product (2021-2032) (USD Billion) 

9.3.4 Europe Shingles Vaccine Market Estimates and Forecasts, By Vaccine Type (2021-2032) (USD Billion)

9.3.5 Germany

9.3.5.1 Germany Shingles Vaccine Market Estimates and Forecasts, By Product (2021-2032) (USD Billion)

9.3.5.2 Germany Shingles Vaccine Market Estimates and Forecasts, By Vaccine Type (2021-2032) (USD Billion)

9.3.6 France

9.3.6.1 France Shingles Vaccine Market Estimates and Forecasts, By Product (2021-2032) (USD Billion)

9.3.6.2 France Shingles Vaccine Market Estimates and Forecasts, By Vaccine Type (2021-2032) (USD Billion)

9.3.7 UK

9.3.7.1 UK Shingles Vaccine Market Estimates and Forecasts, By Product (2021-2032) (USD Billion)

9.3.7.2 UK Shingles Vaccine Market Estimates and Forecasts, By Vaccine Type (2021-2032) (USD Billion)

9.3.8 Italy

9.3.8.1 Italy Shingles Vaccine Market Estimates and Forecasts, By Product (2021-2032) (USD Billion)

9.3.8.2 Italy Shingles Vaccine Market Estimates and Forecasts, By Vaccine Type (2021-2032) (USD Billion)

9.3.9 Spain

9.3.9.1 Spain Shingles Vaccine Market Estimates and Forecasts, By Product (2021-2032) (USD Billion)

9.3.9.2 Spain Shingles Vaccine Market Estimates and Forecasts, By Vaccine Type (2021-2032) (USD Billion)

9.3.10 Poland

9.3.10.1 Poland Shingles Vaccine Market Estimates and Forecasts, By Product (2021-2032) (USD Billion)

9.3.10.2 Poland Shingles Vaccine Market Estimates and Forecasts, By Vaccine Type (2021-2032) (USD Billion)

9.3.11 Turkey

9.3.11.1 Turkey Shingles Vaccine Market Estimates and Forecasts, By Product (2021-2032) (USD Billion)

9.3.11.2 Turkey Shingles Vaccine Market Estimates and Forecasts, By Vaccine Type (2021-2032) (USD Billion)

9.3.12 Rest of Europe

9.3.12.1 Rest of Europe Shingles Vaccine Market Estimates and Forecasts, By Product (2021-2032) (USD Billion)

9.3.12.2 Rest of Europe Shingles Vaccine Market Estimates and Forecasts, By Vaccine Type (2021-2032) (USD Billion)

9.4 Asia Pacific

9.4.1 Trends Analysis

9.4.2 Asia Pacific Shingles Vaccine Market Estimates and Forecasts, by Country (2021-2032) (USD Billion)

9.4.3 Asia Pacific Shingles Vaccine Market Estimates and Forecasts, By Product (2021-2032) (USD Billion) 

9.4.4 Asia Pacific Shingles Vaccine Market Estimates and Forecasts, By Vaccine Type (2021-2032) (USD Billion)

9.4.5 China

9.4.5.1 China Shingles Vaccine Market Estimates and Forecasts, By Product (2021-2032) (USD Billion)

9.4.5.2 China Shingles Vaccine Market Estimates and Forecasts, By Vaccine Type (2021-2032) (USD Billion)

9.4.6 India

9.4.5.1 India Shingles Vaccine Market Estimates and Forecasts, By Product (2021-2032) (USD Billion)

9.4.5.2 India Shingles Vaccine Market Estimates and Forecasts, By Vaccine Type (2021-2032) (USD Billion)

9.4.5 Japan

9.4.5.1 Japan Shingles Vaccine Market Estimates and Forecasts, By Product (2021-2032) (USD Billion)

9.4.5.2 Japan Shingles Vaccine Market Estimates and Forecasts, By Vaccine Type (2021-2032) (USD Billion)

9.4.6 South Korea

9.4.6.1 South Korea Shingles Vaccine Market Estimates and Forecasts, By Product (2021-2032) (USD Billion)

9.4.6.2 South Korea Shingles Vaccine Market Estimates and Forecasts, By Vaccine Type (2021-2032) (USD Billion)

9.4.7 Singapore

9.4.7.1 Singapore Shingles Vaccine Market Estimates and Forecasts, By Product (2021-2032) (USD Billion)

9.4.7.2 Singapore Shingles Vaccine Market Estimates and Forecasts, By Vaccine Type (2021-2032) (USD Billion)

8.4.8 Australia

8.4.8.1 Australia Shingles Vaccine Market Estimates and Forecasts, By Product (2021-2032) (USD Billion)

8.4.8.2 Australia Shingles Vaccine Market Estimates and Forecasts, By Vaccine Type (2021-2032) (USD Billion)

9.4.9 Rest of Asia Pacific

9.4.9.1 Rest of Asia Pacific Shingles Vaccine Market Estimates and Forecasts, By Product (2021-2032) (USD Billion)

9.4.9.2 Rest of Asia Pacific Shingles Vaccine Market Estimates and Forecasts, By Vaccine Type (2021-2032) (USD Billion)

9.5 Middle East & Africa

9.5.1 Trends Analysis

9.5.2 Middle East & Africa Shingles Vaccine Market Estimates and Forecasts, by Country (2021-2032) (USD Billion)

9.5.3 Middle East & Africa Shingles Vaccine Market Estimates and Forecasts, By Product (2021-2032) (USD Billion) 

9.5.4 Middle East & Africa Shingles Vaccine Market Estimates and Forecasts, By Vaccine Type (2021-2032) (USD Billion)

9.5.5 UAE

9.5.5.1 UAE Shingles Vaccine Market Estimates and Forecasts, By Product (2021-2032) (USD Billion)

9.5.5.2 UAE Shingles Vaccine Market Estimates and Forecasts, By Vaccine Type (2021-2032) (USD Billion)

9.5.6 Saudi Arabia

9.5.6.1 Saudi Arabia Shingles Vaccine Market Estimates and Forecasts, By Product (2021-2032) (USD Billion)

9.5.6.2 Saudi Arabia Shingles Vaccine Market Estimates and Forecasts, By Vaccine Type (2021-2032) (USD Billion)

9.5.7 Qatar

9.5.7.1 Qatar Shingles Vaccine Market Estimates and Forecasts, By Product (2021-2032) (USD Billion)

9.5.7.2 Qatar Shingles Vaccine Market Estimates and Forecasts, By Vaccine Type (2021-2032) (USD Billion)

9.5.8 South Africa

9.5.8.1 South Africa Shingles Vaccine Market Estimates and Forecasts, By Product (2021-2032) (USD Billion)

9.5.8.2 South Africa Shingles Vaccine Market Estimates and Forecasts, By Vaccine Type (2021-2032) (USD Billion)

9.5.9 Middle East & Africa

9.5.9.1 Middle East & Africa Shingles Vaccine Market Estimates and Forecasts, By Product (2021-2032) (USD Billion)

9.5.9.2 Middle East & Africa Shingles Vaccine Market Estimates and Forecasts, By Vaccine Type (2021-2032) (USD Billion)

9.6 Latin America

9.6.1 Trends Analysis

9.6.2 Latin America Shingles Vaccine Market Estimates and Forecasts, by Country (2021-2032) (USD Billion)

9.6.3 Latin America Shingles Vaccine Market Estimates and Forecasts, By Product (2021-2032) (USD Billion) 

9.6.4 Latin America Shingles Vaccine Market Estimates and Forecasts, By Vaccine Type (2021-2032) (USD Billion)

9.6.5 Brazil

9.6.5.1 Brazil Shingles Vaccine Market Estimates and Forecasts, By Product (2021-2032) (USD Billion)

9.6.5.2 Brazil Shingles Vaccine Market Estimates and Forecasts, By Vaccine Type (2021-2032) (USD Billion)

9.6.6 Argentina

9.6.6.1 Argentina Shingles Vaccine Market Estimates and Forecasts, By Product (2021-2032) (USD Billion)

9.6.6.2 Argentina Shingles Vaccine Market Estimates and Forecasts, By Vaccine Type (2021-2032) (USD Billion)

9.6.7 Rest of Latin America

9.6.7.1 Rest of Latin America Shingles Vaccine Market Estimates and Forecasts, By Product (2021-2032) (USD Billion)

9.6.7.2 Rest of Latin America Shingles Vaccine Market Estimates and Forecasts, By Vaccine Type (2021-2032) (USD Billion)

10. Company Profiles

           10.1 GlaxoSmithKline (GSK)

                          10.1.1 Company Overview

10.1.2 Financial

10.1.3 Product / Services Offered

10.1.4 SWOT Analysis

           10.2 Vaccitech

                           10.2.1 Company Overview

10.2.2 Financial

10.2.3 Product/ Services Offered

10.2.4 SWOT Analysis

10.3 Jiangsu Recbio Technology Co., Ltd.

              10.3.1 Company Overview

10.3.2 Financial

10.3.3 Product/ Services Offered

10.3.4 SWOT Analysis

10.4 Merck & Co., Inc.

             10.4.1 Company Overview

10.4.2 Financial

10.4.3 Product/ Services Offered

10.4.4 SWOT Analysis

10.5 GeneOne Life Science

             10.5.1 Company Overview

10.5.2 Financial

10.5.3 Product/ Services Offered

10.5.4 SWOT Analysis

10.6 Pfizer Inc.

             10.6.1 Company Overview

10.6.2 Financial

10.6.3 Product/ Services Offered

10.6.4 SWOT Analysis

10.7 SK bioscience

             10.7.1 Company Overview

10.7.2 Financial

10.7.3 Product/ Services Offered

10.7.4 SWOT Analysis

10.8 BioNTech SE

             10.8.1 Company Overview

10.8.2 Financial

10.8.3 Product/ Services Offered

10.8.4 SWOT Analysis

10.9 Changchun BCHT Biotechnology Co.

             10.9.1 Company Overview

10.9.2 Financial

10.9.3 Product/ Services Offered

10.9.4 SWOT Analysis

10.10 Curevo Inc.

             10.10.1 Company Overview

10.10.2 Financial

10.10.3 Product/ Services Offered

10.10.4 SWOT Analysis

11. Use Cases and Best Practices

12. Conclusion